Execs On The Move: Dynatronics Makes Key Personnel Moves; Sientra Gets New CEO
Dynatronics CEO drops chief financial officer job as company hires a new CFO; Sientra gets a new president and CEO; Yourgene Health promotes director of R&D to chief science officer; and more.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.